Novartis AG (NOVN)

Switzerland
Currency in CHF
Disclaimer
82.25
+5.89
(+7.71%)
Closed
Unusual trading volume
Day's Range
79.41
82.46
52 wk Range
73.33
88.41
Volume
10,660,748
Prev. Close
76.36
Open
79.41
Day's Range
79.41-82.46
52 wk Range
73.33-88.41
Volume
10,660,748
Average Volume (3m)
4,734,166
1-Year Change
-5.39%
Shares Outstanding
2,277,477,752
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
97.69
Upside +18.77%

People Also Watch

17.45
UBSG
+1.07%
400.65
OREP
+0.65%
98.44
SASY
+1.38%
1,806.00
HRMS
+1.06%

Novartis AG News

Novartis AG Analysis

Novartis AG Company Profile

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Employees
102000